Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
This study is currently recruiting participants.
Verified June 2013 by Eli Lilly and Company
Study NCT01196091   Information provided by Eli Lilly and Company

First Received on September 3, 2010.   Last Updated on June 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systemic Lupus Erythematosus
Connective Tissue Disease
Autoimmune Disease
Additional conditions recognized in this trial
Autoimmune Diseases
Connective Tissue Diseases
Lupus Erythematosus, Systemic
More general conditions related to this trial
Immune System Diseases
Interventions listed in this trial
LY2127399
Placebo every 2 weeks
Placebo every 4 weeks
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services